U Wagner

Summary

Affiliation: Philipps University
Country: Germany

Publications

  1. ncbi [Parapneumonic effusion and pleural empyema--diagnosis and conservative therapy]
    U Wagner
    , Schwerpunkt Pneumologie,
    Dtsch Med Wochenschr 130:525-9. 2005
  2. ncbi Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat
    U Wagner
    Department of Internal Medicine, Philipps University, Marburg Lahn, Germany
    Neuropeptides 33:55-61. 1999
  3. ncbi [Acute dyspnoea]
    U Wagner
    Klinik fur Innere Medizin, Schwerpunkt Pneumologie, Philipps Universitat Marburg
    Internist (Berl) 46:965-73. 2005
  4. ncbi Current approaches in ovarian cancer vaccines
    S Reinartz
    Department for Gynecology and Obstetrics, University of Marburg, Marburg, Germany
    Minerva Ginecol 56:515-27. 2004
  5. ncbi Survival chances and psychological aspects of quality of life in patients with localized early stage breast cancer
    U S Albert
    Dept of Gynecology, Gynecological Endocrinology and Oncology, Philipps University Marburg, Pilgrimstein 3, 35037, Marburg, Germany
    Inflamm Res 53:S136-41. 2004
  6. ncbi [Mammographic breast density and breast cancer risk during HRT]
    K Bock
    Klinik fur Gynakologie, Gynäkologische Endokrinologie und Onkologie der Philipps Unversität Marburg
    Zentralbl Gynakol 127:217-21. 2005
  7. ncbi [Differential diagnosis of Poland-syndrome versus unilateral accentuated thelarche]
    K Bock
    Klinik fur Gynakologie, Gynäkologische Endokrinologie und Onkologie der Philipps Universität Marburg
    Ultraschall Med 25:377-82. 2004
  8. ncbi Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer
    V Ziller
    Department of Gynaecology, Gynaecological Endocrinology and Oncology, Philipps University of Marburg, Marburg, Germany
    Ann Oncol 20:431-6. 2009
  9. ncbi [Evaluation of quantitative ultrasonometry of bone in singleton and multiple pregnancies]
    L Hellmeyer
    Klinik für Geburtshilfe und Perinatalmedizin, Philipps Universitat Marburg, Marburg
    Z Geburtshilfe Neonatol 210:179-83. 2006
  10. ncbi [Summary of the updated stage 3 guideline for early detection of breast cancer in Germany 2008]
    U-S Albert

    Rofo 180:455-65. 2008

Detail Information

Publications45

  1. ncbi [Parapneumonic effusion and pleural empyema--diagnosis and conservative therapy]
    U Wagner
    , Schwerpunkt Pneumologie,
    Dtsch Med Wochenschr 130:525-9. 2005
  2. ncbi Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat
    U Wagner
    Department of Internal Medicine, Philipps University, Marburg Lahn, Germany
    Neuropeptides 33:55-61. 1999
    ..The present data suggest that the secretagogue effects elicited by tachykinins in rat trachea are mediated via NK(1)receptors...
  3. ncbi [Acute dyspnoea]
    U Wagner
    Klinik fur Innere Medizin, Schwerpunkt Pneumologie, Philipps Universitat Marburg
    Internist (Berl) 46:965-73. 2005
    ..Therefore, it is of utmost importance to identify the cause of dyspnoea immediately. Once found, the disorder is treated according to the guidelines for the underlying disease...
  4. ncbi Current approaches in ovarian cancer vaccines
    S Reinartz
    Department for Gynecology and Obstetrics, University of Marburg, Marburg, Germany
    Minerva Ginecol 56:515-27. 2004
    ..g. by vaccines targeting a broader range of tumor-derived antigenic structures or activating diverse host immune functions, will be discussed...
  5. ncbi Survival chances and psychological aspects of quality of life in patients with localized early stage breast cancer
    U S Albert
    Dept of Gynecology, Gynecological Endocrinology and Oncology, Philipps University Marburg, Pilgrimstein 3, 35037, Marburg, Germany
    Inflamm Res 53:S136-41. 2004
    ....
  6. ncbi [Mammographic breast density and breast cancer risk during HRT]
    K Bock
    Klinik fur Gynakologie, Gynäkologische Endokrinologie und Onkologie der Philipps Unversität Marburg
    Zentralbl Gynakol 127:217-21. 2005
    ..In symptomatic women with dense breasts, additive breast ultrasound is strongly recommended to reduce the otherwise high rate of missed breast cancers...
  7. ncbi [Differential diagnosis of Poland-syndrome versus unilateral accentuated thelarche]
    K Bock
    Klinik fur Gynakologie, Gynäkologische Endokrinologie und Onkologie der Philipps Universität Marburg
    Ultraschall Med 25:377-82. 2004
    ..We report the value of panoramic-sonography in the diagnosis of this rare condition in three patients...
  8. ncbi Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer
    V Ziller
    Department of Gynaecology, Gynaecological Endocrinology and Oncology, Philipps University of Marburg, Marburg, Germany
    Ann Oncol 20:431-6. 2009
    ..The aim of this study was to evaluate the rate of adherent patients in a randomly selected sample of postmenopausal women with primary breast cancer, who had been assigned to an adjuvant endocrine treatment with TAM or anastrozole (ANA)...
  9. ncbi [Evaluation of quantitative ultrasonometry of bone in singleton and multiple pregnancies]
    L Hellmeyer
    Klinik für Geburtshilfe und Perinatalmedizin, Philipps Universitat Marburg, Marburg
    Z Geburtshilfe Neonatol 210:179-83. 2006
    ..Therefore we have investigated whether a decrease in maternal bone mineral density (BMD) can be observed during pregnancy and whether it differs between singleton and twin pregnancies...
  10. ncbi [Summary of the updated stage 3 guideline for early detection of breast cancer in Germany 2008]
    U-S Albert

    Rofo 180:455-65. 2008
  11. ncbi Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT)
    P Hadji
    Philipps University of Marburg, Department of Gynaecology, Gynaecological Oncology and Endocrinology, Pilgrimstein 3, D 35037 Marburg, Germany
    Maturitas 56:312-21. 2007
    ....
  12. ncbi Stress and strain in teaching: a structural equation approach
    R van Dick
    Faculty of Psychology, Philipps University Marburg, Germany
    Br J Educ Psychol 71:243-59. 2001
    ..The stress model of Lazarus and colleagues and its adaptation to educational settings by Kyriacou and Sutcliffe is the basis for an analysis of antecedents and consequences of teacher stress...
  13. ncbi [Guideline for the Early Detection of Breast Cancer in Germany 2008. Recommendations from the short version]
    U S Albert
    Planungskommission und Arbeitsgruppenleiter der Konzertierten Aktion Brustkrebs Früherkennung in Deutschland, Deutschland
    Chirurg 79:589-94. 2008
    ..The long version of the Guideline, methods report, and evidence report are available on the internet at www.awmf-leitlinien.de (reg. no. 077/001) with free access...
  14. ncbi The status of neck node metastases in breast cancer--loco-regional or distant?
    A M Sesterhenn
    Department of Otolaryngology, Head and Neck Surgery, Philipps University, Deutschhausstrasse 3, D 35037 Marburg, Germany
    Breast 15:181-6. 2006
    ..This important question remains unanswered and deserves clarification in the current classification of the AJCC Staging System for Breast Cancer...
  15. ncbi [Acute exacerbation of COPD]
    R Bals
    , , Standort Marburg, Marburg
    Pneumologie 60:11-23; quiz 24-5. 2006
  16. ncbi [Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO]
    B Schmalfeldt
    Frauenklinik der Technischen Universitat Munchen, Ismaninger Str 2, 81675 Munchen
    Zentralbl Gynakol 128:11-7. 2006
    ..A short version of these guidelines is presented...
  17. ncbi [T-lymphocytes--do they control rheumatic immune responses?]
    U Wagner
    Medizinische Klinik und Poliklinik IV, Universitat Leipzig, Liebigstrasse 22, 04103 Leipzig, Germany
    Z Rheumatol 64:377-82. 2005
    ..Here, we review the functional abnormalities and the contribution of different T-cell subsets to rheumatoid inflammation...
  18. ncbi [Lymphedema in patients with breast cancer--a consensus regarding diagnostics and therapy in patients with postoperative lymphedema after primary breast cancer]
    U Seifart
    Hamm Kliniken, Bad Soden Salmünster
    Rehabilitation (Stuttg) 46:340-8. 2007
    ..The need for improving oncological management for early diagnosis and referral for effective treatment of lymphedema is a major goal of breast cancer heath care while survival improves...
  19. ncbi [Cardiovascular manifestations in rheumatoid arthritis]
    F Moritz
    Center of Experimental Rheumatology and WHO Collaborating Center for Molecular Biology and Novel Therapeutic Strategies, University Hospital, , Switzerland, Gloriastr. 25, 8091, , Switzerland
    Z Rheumatol 64:222-8. 2005
    ..Time will show whether they make a remarkable impact on the cardiovascular mortality in RA patients...
  20. ncbi [T cell-dependent monocyte activation, TNFalpha and apolipoprotein A-I in autoimmunity and inflammation]
    M Rossol
    Medizinische Klinik und Poliklinik IV, , Liebigstr. 22, 04103, Leipzig, Germany
    Z Rheumatol 64:249-54. 2005
    ..In patients with rheumatoid arthritis, apolipoprotein A-I is found in decreased concentrations, possibly due to its role as a negative acute phase protein. The role of this and other inhibitory serum molecules are discussed...
  21. ncbi High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer
    R Simon
    Institute for Pathology and Urologic Clinics, University of Basel, Schoenbeinstrasse 40, CH-4031 Basel, Switzerland
    Cancer Res 61:4514-9. 2001
    ..05). The marked differences in the frequency of all of the analyzed changes between pTa grade 1/grade 2 and pT1-4 carcinomas support the concept of these tumor groups representing different tumor entities...
  22. ncbi Integration of new or experimental treatment options and new approaches to clinical trials
    M Quinn
    Oncology Unit, Royal Women's Hospital, Carlton, Australia
    Ann Oncol 16:viii30-viii35. 2005
  23. ncbi 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration
    G Stuart
    NCIC-CTG, Canada
    Ann Oncol 16:viii36-viii38. 2005
  24. ncbi Bone metastases in vulvar cancer: a rare metastatic pattern
    F Fischer
    Department of Gynecology, University Hospital Marburg, Marburg, Germany
    Int J Gynecol Cancer 15:1173-6. 2005
    ..The atypical location should alert the physician to suspect distant metastasis, rather than locoregional disease...
  25. ncbi Promoter polymorphisms regulating corticotrophin-releasing hormone transcription in vitro
    U Wagner
    Department of Internal Medicine IV, Division of Rheumatology, Neuroendocrine Immunology Laboratory, University Hospital Leipzig, Germany
    Horm Metab Res 38:69-75. 2006
    ..Taken together, this is the first study to demonstrate that CRH promoter reactivity varies between the compound promoter alleles...
  26. ncbi 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
    A Du Bois
    Department of Gynecology and Gynecologic Oncology, Wiesbaden, Germany
    Ann Oncol 16:viii7-viii12. 2005
  27. ncbi A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC-IV (AGO-OVAR protocol OVAR-8)
    A Du Bois
    Department of Gynecology and Gynecologic Oncology, and AGO Study Secretary, Dr Horst Schmidt Klinik Wiesbaden HSK, Ludwig Erhard Str 100, D 65199 Wiesbaden, Germany
    Gynecol Oncol 96:444-51. 2005
    ..A multicenter, nonrandomized, phase II study was initiated to evaluate the tolerability, toxicity, and activity of paclitaxel, carboplatin, and gemcitabine combination in previously untreated ovarian cancer...
  28. ncbi Metabolism of L(-)-carnitine by Enterobacteriaceae under aerobic conditions
    T Elssner
    Institut fur Biochemie, Universitat Leipzig, Germany
    FEMS Microbiol Lett 174:295-301. 1999
    ..coli ATCC 25922, P. vulgaris, P. mirabilis, Citrobacter freundii, Enterobacter cloacae and Klebsiella pneumoniae) grown under aerobic conditions in the presence of L(-)-carnitine...
  29. ncbi Molecular cytogenetic alterations associated with rapid tumor cell proliferation in advanced urinary bladder cancer
    S Tomovska
    Institute of Pathology, University of Basel, 4031 Basel, Switzerland
    Int J Oncol 18:1239-44. 2001
    ..The particular strong association between 6p+ and a high tumor cell proliferation being independent of grade and stage suggests that a putative oncogene on 6p22 involved in cell cycle regulation...
  30. ncbi Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade
    A Nocito
    Institute for Pathology, University of Basel, Schoenbeinstrasse 40, CH-4003 Basel, Switzerland
    J Pathol 194:349-57. 2001
    ..TMAs are a powerful tool for rapid identification of the biological or clinical significance of molecular alterations in bladder cancer and other tumour types...
  31. ncbi Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling
    S Mousses
    Cancer Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD 20892, USA
    Oncogene 20:6718-23. 2001
    ....
  32. ncbi A caged Ab reveals an immediate/instructive effect of BDNF during hippocampal synaptic potentiation
    A H Kossel
    , , Germany
    Proc Natl Acad Sci U S A 98:14702-7. 2001
    ..The results additionally show that caged Abs can provide a tool for precise spatiotemporal control over endogenous protein levels...
  33. ncbi Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer
    Bois A du
    Department of Gynecology and Gynecologic Oncology, Dr Horst Schmidt Kliniken Wiesbaden, Germany
    Ann Oncol 13:251-7. 2002
    ..Here we evaluate whether a second-line chemotherapy can offer any benefit compared with a less toxic hormonal treatment...
  34. ncbi The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer
    J Huober
    University of Tuebingen, Dept of Gynecology and Obstetrics, Schleichstrasse 4, 72076 Tuebingen, Germany
    J Cancer Res Clin Oncol 128:153-60. 2002
    ..The available data is presented and discussed in this review...
  35. ncbi [What common grounds exist in the pathomechanism of Sjögren disease and associated hematologic diseases? From autoreactive B cell activation and T cell cooperation to B-cell lymphoma. Pathogenesis of lymphoproliferations in patients with Sjögren syndrom
    U Wagner
    , 04107 Leipzig, Germany
    Z Rheumatol 61:209-11. 2002
  36. ncbi [HER-2 and TOP 2A gene amplifications in urinary bladder carcinoma]
    R Simon
    , , Schweiz
    Verh Dtsch Ges Pathol 86:176-83. 2002
    ..Given the high frequency of HER-2 amplification in urinary bladder cancer, some of these tumors may respond favorable to Herceptin therapy. The TOP2A amplification status may influence response to anthracyclin treatment...
  37. ncbi [HER-2 and TOP2A gene amplification in urinary bladder cancer]
    R Simon
    Verh Dtsch Ges Pathol 86:176-83. 2002
  38. ncbi Analysis of exotoxins produced by atypical isolates of Aeromonas salmonicida, by enzymatic and serological methods
    B K Gudmundsdottir
    Institute for Experimental Pathology, University of Iceland, Reykjavik, Iceland
    J Fish Dis 26:15-29. 2003
    ..The combination of zymogram and serological detection used is recommended as the most reliable method for characterizing A. salmonicida strains according to their exotoxin secretion...
  39. ncbi State-of-the-art first-line treatment of ovarian cancer
    J Pfisterer
    Klinik für Gynäkologie und Geburtshilfe Campus Kiel, Universitatsklinikum Schleswig Holstein, Kiel, Germany
    Onkologie 26:446-50. 2003
    ..All items are discussed in detail...
  40. ncbi [Advances in the treatment of ovarian carcinoma]
    J Pfisterer
    ,
    Dtsch Med Wochenschr 129:379-84. 2004
  41. ncbi Docetaxel and carboplatin as first-line chemotherapy in patients with advanced gynecological tumors. A phase I/II trial of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group
    J Pfisterer
    Klinik fur Gynakologie und Geburtshilfe, Campus Kiel Universitätsklinikum Schleswig Holstein, Germany
    Gynecol Oncol 92:949-56. 2004
    ..We performed a phase I-II study in patients with ovarian and other gynecological cancers to determine the dose-limiting toxicities, maximum tolerated dose (MTD) and efficacy of docetaxel/carboplatin...
  42. ncbi Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer
    N Fersis
    Department of Gynaecology, University of Tuebingen, Tuebingen, Germany
    Eur J Gynaecol Oncol 25:339-42. 2004
    ..In order to improve this technique as a standard procedure for staging of endometrial cancer further studies with a larger number of patients have to be done...
  43. ncbi Improving first-line therapy of advanced ovarian cancer - the AGO Ovarian Cancer Study Group perspective
    A Du Bois
    Department of Gynecology and Gynecologic Oncology, Dr Horst Schmidt Kliniken, Wiesbaden, Germany
    Int J Gynecol Cancer 13:169-71. 2003
    ....
  44. ncbi Crotonobetaine reductase from Escherichia coli consists of two proteins
    A Preusser
    Institut fur Biochemie, Fakultat fur Biowissenschaften, Pharmazie und Psychologie, Universitat Leipzig, Talstr 33, D 04103, Leipzig, Germany
    Biochim Biophys Acta 1431:166-78. 1999
    ..A still unknown low-molecular-mass effector described for the l(-)-carnitine dehydratase is also necessary for crotonobetaine reductase activity. Monoclonal antibodies were raised against the two components of crotonobetaine reductase...